Clinical Trial

Cardiac Injury Due to Anthracycline in Paediatric Oncological Patients

Recruiting
View on ClinicalTrials.gov →
Summary
The study investigates the role of echocardiography and of serum biomarkers (NT-proBNP, cardiac Troponin-I) in predicting cardiac injury in a cohort of paediatric oncological patients treated with Anthracycline chemotherapy.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-03-20.
Trial Details
NCT Number NCT06898320
Lead Sponsor IRCCS Burlo Garofolo
Conditions Heart Injuries, Anthracycline
Enrollment 22 participants
Start Date 2023-07-21
Primary Completion 2033-07-21 (estimated)
Study Completion 2033-07-21 (estimated)
Updated on ClinicalTrials.gov 2025-05-09